tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

OCGN Stock Latest News

Ocugen strengthens balance sheet with new equity financing
Company AnnouncementsOcugen strengthens balance sheet with new equity financing
10d ago
8K
OCGN
Ocugen: Promising OCU410 Phase 2 Efficacy, Strengthened Balance Sheet, and Large GA Market Opportunity Support Buy Rating
PremiumRatings
Ocugen: Promising OCU410 Phase 2 Efficacy, Strengthened Balance Sheet, and Large GA Market Opportunity Support Buy Rating
11d ago
OCGN
Ocugen Announces $22.5 Million Public Stock Offering
PremiumCompany Announcements
Ocugen Announces $22.5 Million Public Stock Offering
12d ago
8K
OCGN
Midday Fly By: Netflix reports Q4 beat, Smithfield to acquire Nathan’s
PremiumThe Fly
Midday Fly By: Netflix reports Q4 beat, Smithfield to acquire Nathan’s
12d ago
DB
ANF
Ocugen prices 15M shares at $1.50 in underwritten offering
PremiumThe Fly
Ocugen prices 15M shares at $1.50 in underwritten offering
12d ago
OCGN
Midday Fly By: TSMC reports Q4 beat, Goldman Sachs raises dividend
PremiumThe FlyMidday Fly By: TSMC reports Q4 beat, Goldman Sachs raises dividend
18d ago
BA
GS
Ocugen Reports Encouraging 12-Month Data for OCU410
Premium
Company Announcements
Ocugen Reports Encouraging 12-Month Data for OCU410
18d ago
8K
OCGN
Ocugen announces preliminary data from Phase 2 ArMaDa study
Premium
The Fly
Ocugen announces preliminary data from Phase 2 ArMaDa study
18d ago
OCGN
3 ‘Strong Buy’ Small Cap Stocks to Buy for 2026, According to Analysts
PremiumMarket News
3 ‘Strong Buy’ Small Cap Stocks to Buy for 2026, According to Analysts
19d ago
ALLO
BTBT
Ocugen announces publication of Phase 1 GARDian1 trial results for OCU410ST
PremiumThe Fly
Ocugen announces publication of Phase 1 GARDian1 trial results for OCU410ST
21d ago
OCGN
Ocugen Grants CEO New Performance-Based Equity Award
PremiumCompany Announcements
Ocugen Grants CEO New Performance-Based Equity Award
2M ago
8K
OCGN
Ocugen’s Clinical Progress and Strategic Positioning Drive Buy Rating and Increased Price Target
PremiumRatings
Ocugen’s Clinical Progress and Strategic Positioning Drive Buy Rating and Increased Price Target
3M ago
OCGN
Ocugen’s Promising Gene Therapy Progress and Financial Stability Drive Buy Rating
PremiumRatingsOcugen’s Promising Gene Therapy Progress and Financial Stability Drive Buy Rating
3M ago
OCGN
Ocugen Reports Progress in Gene Therapy Trials Amid Financial Losses
Premium
Company Announcements
Ocugen Reports Progress in Gene Therapy Trials Amid Financial Losses
3M ago
OCGN
Ocugen Inc. Earnings Call: Gene Therapy Advances Amid Financial Challenges
Premium
Company Announcements
Ocugen Inc. Earnings Call: Gene Therapy Advances Amid Financial Challenges
3M ago
OCGN
OCGN Earnings this Week: How Will it Perform?
PremiumPre-Earnings
OCGN Earnings this Week: How Will it Perform?
3M ago
OCGN
Ocugen’s Promising Phase 2/3 Trial for Stargardt Disease: A Potential Game-Changer
PremiumCompany Announcements
Ocugen’s Promising Phase 2/3 Trial for Stargardt Disease: A Potential Game-Changer
3M ago
OCGN
Ocugen’s Phase 3 Gene Therapy Trial: A Potential Game-Changer for Retinitis Pigmentosa
PremiumCompany Announcements
Ocugen’s Phase 3 Gene Therapy Trial: A Potential Game-Changer for Retinitis Pigmentosa
3M ago
OCGN
Ocugen’s OCU200 Study: A Potential Game-Changer for Diabetic Macular Edema
PremiumCompany Announcements
Ocugen’s OCU200 Study: A Potential Game-Changer for Diabetic Macular Edema
3M ago
OCGN
Ocugen initiated with a Buy at Lucid Capital
PremiumThe FlyOcugen initiated with a Buy at Lucid Capital
4M ago
OCGN
Ocugen Faces Merger Termination with Carisma Therapeutics
Premium
Company Announcements
Ocugen Faces Merger Termination with Carisma Therapeutics
5M ago
8K
OCGN
Ocugen’s Strategic Advancements and Promising Prospects Justify Buy Rating
Premium
Ratings
Ocugen’s Strategic Advancements and Promising Prospects Justify Buy Rating
5M ago
OCGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >